UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
37.94
+1.14 (3.10%)
At close: Jul 1, 2026, 4:00 PM EDT
37.94
0.00 (0.00%)
After-hours: Jul 1, 2026, 5:29 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.85 billion as of July 1, 2026. Its market cap has increased by 179.57% in one year.
Market Cap
1.85B
Enterprise Value
1.91B
1-Year Change
179.57%
Ranking
Category
Stock Price
$37.94
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.85B, an increase of 916.22%. That is a compound annual growth rate of 28.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 1.85B | 68.61% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.91B |
| Sarepta Therapeutics | 1.90B |
| Tyra Biosciences | 1.89B |
| Iovance Biotherapeutics | 1.86B |
| GH Research | 1.85B |
| Nanobiotix | 1.80B |
| Aktis Oncology | 1.78B |
| Hemab Therapeutics Holdings | 1.75B |